publication venue for
- Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.. 177:29-40. 2019
- ER splice variant expression in four large cohorts of human breast cancer patient tumors.. 146:657-667. 2014
- The effect of atmospheric particulate matter on survival of breast cancer among US females.. 139:217-226. 2013
- Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation.. 136:21-34. 2012
- Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006.. 131:231-238. 2012
- P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis.. 130:399-408. 2011
- Fertility drugs and the risk of breast cancer: a meta-analysis and review.. 124:13-26. 2010
- 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.. 109:273-283. 2008
- Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats.. 66:147-157. 2001
- Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.. 61:197-210. 2000
- IL-8 is involved in the development and growth of osteolytic bone lesions. 2005
- Therapeutic modulation of anti-estrogen resistance through histone deacetylase inhibition. 2005
- Effect of glutamine on radiation morbidity in breast conservaton therapy is associated with a novel protein marker. 2004